• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Merge posts big revenue gain

Article

Connectivity firm Merge Technologies reported 55% revenue growth in its first quarter as a public company. The Milwaukee-based software developer credited new product sales and an expanded sales force for the strong performance.For the period

Connectivity firm Merge Technologies reported 55% revenue growth in its first quarter as a public company. The Milwaukee-based software developer credited new product sales and an expanded sales force for the strong performance.

For the period (end-March), Merge posted revenues of $2.6 million, compared with $1.7 million in 1997. The company had a net loss of $56,000, compared with a net loss of $45,000 in the same period last year.

In quarterly highlights, Merge shipped two beta units of its CD-based MergeARK archiving offering. The firm also has been granted a patent for CaseWorks, the first product in Merge’s line of Networked Image Management offerings, which the company believes will facilitate the development of electronic patient records. CaseWorks is a radiology work-flow management tool that uses a MergeReader hand-held unit to mark films that should be included in a patient’s EPR. Merge expects CaseWorks to begin shipping in mid-1998.

Since Merge’s debut on the NASDAQ SmallCap Market in January, the company’s stock has seen its share price climb to a high of $7, before falling below its initial public offering price of $6. As of May 4, Merge shares closed at $5.03, down 16.2% from the IPO price.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.